These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 34000255)

  • 21. COVID-19 convalescent plasma therapy: hit fast, hit hard!
    Focosi D; Franchini M
    Vox Sang; 2021 Oct; 116(9):935-942. PubMed ID: 33794556
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 convalescent plasma; time for "goal directed therapy"?
    Knudson CM; Jackson JB
    Transfusion; 2021 May; 61(5):1654-1656. PubMed ID: 33723852
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer.
    Bloch EM; Crowe EP; Tobian AAR
    J Infect Dis; 2021 Mar; 223(5):740-742. PubMed ID: 33411937
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients.
    Pal P; Ibrahim M; Niu A; Zwezdaryk KJ; Tatje E; Robinson WR; Ko L; Satyavarapu I; Jones WE; Nachabe A; Luk A; Mushatt DM; Halvorson K; Denson JL; Smith CC; Simeone F; Davis G; Gill SK; McDougal A; Vigh AS; Peterson TG; Ning B; Hu T; Socola F; Robinson J; Safah H; Saba NS
    Transfus Med; 2021 Jun; 31(3):217-220. PubMed ID: 33073895
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.
    Vuk T; Hećimović A; Jukić I; Ravlić S; Kurtović T; Rnjak D; Halassy B
    Transfus Clin Biol; 2021 Nov; 28(4):424-425. PubMed ID: 34172379
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new alternative: convalescent plasma therapy, possible antidote in times of COVID-19].
    Bendezú Palacio A; Parejas Sosa C; Chunga Tume P
    Medicina (B Aires); 2021; 81(2):307. PubMed ID: 33906157
    [No Abstract]   [Full Text] [Related]  

  • 27. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.
    Al-Riyami AZ; Burnouf T; Yazer M; Triulzi D; Kumaş LT; Sağdur L; Pelit NB; Bazin R; Hindawi SI; Badawi MA; Patidar GK; Pandey HC; Chaurasia R; Fachini RM; Scuracchio P; Wendel S; Ang AL; Ong KH; Young P; Ihalainen J; Vierikko A; Qiu Y; Yang R; Xu H; Rahimi-Levene N; Shinar E; Izak M; Gonzalez CA; Ferrari DM; Cini PV; Aditya RN; Sharma RR; Sachdev S; Hans R; Lamba DS; Nissen-Meyer LSH; Devine DV; Lee CK; Leung JN; Hung IFN; Tiberghien P; Gallian P; Morel P; Al Maamari K; Al-Hinai Z; Vrielink H; So-Osman C; De Angelis V; Berti P; Ostuni A; Marano G; Nevessignsky MT; El Ekiaby M; Daly J; Hoad V; Kim S; van den Berg K; Vermeulen M; Glatt TN; Schäfer R; Reik R; Gammon R; Lopez M; Estcourt L; MacLennan S; Roberts D; Louw V; Dunbar N;
    Vox Sang; 2021 Nov; 116(10):1117-1135. PubMed ID: 34013968
    [No Abstract]   [Full Text] [Related]  

  • 28. Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Farag YMK
    Mayo Clin Proc; 2020 Dec; 95(12):2801-2802. PubMed ID: 33276848
    [No Abstract]   [Full Text] [Related]  

  • 29. High-titer convalescent plasma therapy for coronavirus disease 2019 and mortality.
    Cruciani M; Bongiovanni G; Franchini M
    Transfusion; 2021 Jun; 61(6):1988-1990. PubMed ID: 33913168
    [No Abstract]   [Full Text] [Related]  

  • 30. Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.
    McKemey E; Shields AM; Faustini SE; Hill HJ; Barnskaya A; Stamataki Z; Gompertz S; Richter AG; Dosanjh D; Madathil S
    J Clin Immunol; 2021 Jul; 41(5):926-929. PubMed ID: 33611660
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment on: Nature and Dimensions of the Systemic Hyper-inflammation and Its Attenuation by Convalescent Plasma in Severe COVID-19.
    Acosta-Ampudia Y; Rojas M; Monsalve DM; Rodríguez Y; Ramírez-Santana C; Anaya JM
    J Infect Dis; 2021 May; 223(10):1833-1834. PubMed ID: 33715012
    [No Abstract]   [Full Text] [Related]  

  • 32. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Joyner MJ; Senefeld JW; Klassen SA; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2020 Dec; 95(12):2802-2803. PubMed ID: 33276849
    [No Abstract]   [Full Text] [Related]  

  • 33. In patients hospitalized with COVID-19, adding convalescent plasma to usual care did not reduce 28-d mortality.
    Dionne JC; Oczkowski SJW
    Ann Intern Med; 2021 Oct; 174(10):JC113. PubMed ID: 34606320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response).
    De Santis GC; Calado RT
    Emerg Infect Dis; 2022 May; 28(5):1083-1084. PubMed ID: 35447061
    [No Abstract]   [Full Text] [Related]  

  • 36. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
    Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
    Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19.
    Al-Tawfiq JA; Arabi Y
    Hum Vaccin Immunother; 2020 Dec; 16(12):2973-2979. PubMed ID: 32881641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
    Focosi D; Casadevall A
    Emerg Infect Dis; 2022 May; 28(5):1083. PubMed ID: 35450567
    [No Abstract]   [Full Text] [Related]  

  • 39. Why should we use convalescent plasma for COVID-19?
    Franchini M
    Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
    [No Abstract]   [Full Text] [Related]  

  • 40. Convalescent plasma for COVID-19 - encouraging signals of efficacy.
    Casadevall A; Tobian AAR
    Br J Haematol; 2021 Feb; 192(4):681-682. PubMed ID: 33524158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.